Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
About this item
Full title
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2015
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-March 17, 2015-Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera (C)2015 M2 COMMUNICATIONS http://www.m2.com Biopharmaceutical company Incyte (Nasdaq: INCY) revealed on Monday that it has received European Commission's approval for Jakavi (ruxolitinib) for the...
Alternative Titles
Full title
Incyte wins European Commission approval for Jakavi for treating Polycythemia Vera
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1663798772
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1663798772
How to access this item
Log in as a Library member
